naproxen has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aisa, MC; Datti, A; Di Renzo, GC; Orlacchio, A | 1 |
| Arantes-Rodrigues, R; Correia, I; Gaivão, I; Pinto-Leite, R | 1 |
2 other study(ies) available for naproxen and Osteogenic Sarcoma
| Article | Year |
|---|---|
COX inhibitors and bone: A safer impact on osteoblasts by NO-releasing NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bone Neoplasms; Cathepsin B; Cell Differentiation; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Humans; Metalloproteases; Naproxen; Nitric Oxide; Osteoblasts; Osteosarcoma; Plasminogen Activators; Tumor Cells, Cultured | 2018 |
Effects of naproxen on cell proliferation and genotoxicity in MG-63 osteosarcoma cell line.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Line, Tumor; Cell Proliferation; Comet Assay; DNA Damage; Humans; In Situ Nick-End Labeling; Naproxen; Osteosarcoma | 2014 |